Skip to content
Screener

Fulgent Genetics, Inc. FLGT Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$207M+6.7%
Myriad Genetics logo
Myriad GeneticsMYGN
$7.1M-34.9%
Labcorp Holdings logo
Labcorp HoldingsLH
$180.3M-3.1%
Quest Diagnostics logo
Quest DiagnosticsDGX
$180M+5.3%
NeoGenomics logo
NeoGenomicsNEO
$3.72M-8.1%
Natera, Inc. logo
Natera, Inc.NTRA
$15.12M+15.8%

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$526.64M-16.5%
Enterprise value$511.45M-6.7%
P/S1.6×-0.4×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 7:08 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-199065
Line itemMarch 31, 2026December 31, 2025
Accrued legal liabilities$14,620$14,905
Payroll liabilities7,2944,383
Vacation accrual6,2045,236
Accrued bonus and commission2,3765,224
Operating lease liabilities - short term1,9321,462
Other accrued liabilities2,4752,847
Total$34,901$34,057

Item 1. Financial Statements.

FAQ

What is Fulgent Genetics, Inc.'s operating lease liabilities (current)?
Fulgent Genetics, Inc. (FLGT) reported operating lease liabilities (current) of $1.93M in Q1 2026.
How has Fulgent Genetics, Inc.'s operating lease liabilities (current) changed year-over-year?
Fulgent Genetics, Inc.'s operating lease liabilities (current) increased by 45.3% year-over-year, from $1.33M to $1.93M.
What is the long-term trend for Fulgent Genetics, Inc.'s operating lease liabilities (current)?
Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s operating lease liabilities (current) has grown at a 40.5% compound annual growth rate (CAGR), from $267K to $1.46M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about Fulgent Genetics, Inc.'s operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude